Metabolic convergence of diabetes and prostate cancer: from dysglycemia to tumor microenvironment reprogramming
Mammalian Genome · 2026
DOI: 10.1007/s00335-026-10274-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mammalian Genome, 2026. Verfasst von Anirban Goutam Mukherjee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Sciences, School of Sciences and Humanities, SR University, Warangal, Telangana, 506371, India. mukherjee1anirban@gmail.com. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Tumor Microenvironment, Diabetes Mellitus. Die Arbeit nennt 222 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The relationship between diabetes mellitus and prostate cancer (PC) represents one of the most intriguing paradoxes in cancer epidemiology, with diabetic individuals exhibiting a reduced incidence of PC yet poorer prognosis following diagnosis. This apparent contradiction underscores the need for an integrated understanding of how systemic metabolic dysfunction influences prostate carcinogenesis and disease progression. The present review critically synthesizes contemporary epidemiological, mechanistic, and translational evidence to establish metabolic convergence as a unifying framework linking diabetes-associated metabolic abnormalities with PC biology. Current evidence indicates that chronic dysglycemia, hyperinsulinemia, insulin resistance, and endocrine perturbations orchestrate interconnected intracellular signaling networks involving PI3K-AKT-mTOR, AMPK, AGE-RAGE signaling, oxidative stress, mitochondrial dysfunction, and epigenetic reprogramming, collectively driving metabolic adaptation and tumor evolution. Beyond tumor-intrinsic mechanisms, diabetes profoundly remodels the prostate tumor microenvironment through alterations in stromal metabolism, cancer-associated fibroblast activation, adipocyte-tumor crosstalk, extracellular matrix (ECM) remodeling, hypoxic adaptation, and vascular dysfunction, while simultaneously promoting immunometabolic reprogramming characterized by macrophage polarization, T-cell dysfunction, immune checkpoint activation, and immune evasion. The review further examines the bidirectional interactions between antidiabetic therapies and PC treatment, critically evaluating the translational potential of metformin and emerging glucose-lowering agents within the context of precision metabolic therapeutics. Finally, future directions encompassing biomarker-guided patient stratification, longitudinal metabolic profiling, multi-omics integration, artificial intelligence, and clinically relevant mechanistic validation are discussed as essential components of next-generation precision oncology. Collectively, this review reframes diabetes as an active metabolic determinant of PC rather than a coincidental comorbidity and highlights metabolism-centered precision strategies as promising avenues for improving risk stratification, therapeutic decision-making, and clinical outcomes in diabetes-associated PC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic Sciences, School of Sciences and Humanities, SR University, Warangal, Telangana, 506371, India. mukherjee1anirban@gmail.com.
- Department of Biomedical Sciences, School of Bio-Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
- Department of Biotechnology, School of Life Sciences (Ooty Campus), JSS Academy of Higher Education and Research, Longwood, Ooty, Tamil Nadu, 643001, India.
ORCID-Profile: Anirban Goutam Mukherjee
Zitieren
APA
Mukherjee, A. G., Bharti, A. K., Mathew, D. M., Gopalakrishnan, A. V., & Nishu, S. (2026). Metabolic convergence of diabetes and prostate cancer: from dysglycemia to tumor microenvironment reprogramming. Mammalian Genome. https://doi.org/10.1007/s00335-026-10274-9
Vancouver
Mukherjee AG, Bharti AK, Mathew DM, Gopalakrishnan AV, Nishu S. Metabolic convergence of diabetes and prostate cancer: from dysglycemia to tumor microenvironment reprogramming. Mammalian Genome. 2026. doi:10.1007/s00335-026-10274-9
BibTeX
@article{Mukherjee2026,
author = {Mukherjee, Anirban Goutam and Bharti, Ankit Kumar and Mathew, Deepthi Maria and Gopalakrishnan, Abilash Valsala and Nishu, S},
title = {Metabolic convergence of diabetes and prostate cancer: from dysglycemia to tumor microenvironment reprogramming},
journal = {Mammalian Genome},
year = {2026},
doi = {10.1007/s00335-026-10274-9}
}
EUVIMED